1. A portfolio manager holds a long position in a stock and wants to hedge using put options. If the stock has a delta of 0.75 and a gamma of 0.05, what is the approximate delta of a 1-month put option (assume European style)?
2. Explain the relationship between Value-at-Risk (VaR) and Conditional Value-at-Risk (CVaR). Under what market conditions would CVaR be significantly higher than VaR?
3. A hedge fund calculates a rolling 20-day VaR at the 95% confidence level of $2M. What does this mean in terms of expected losses, and what are the limitations of using VaR for risk measurement?
4. How would you construct a minimum variance portfolio using 50 assets with incomplete correlation matrix data? What imputation methods would you consider?
5. A portfolio has a Sharpe ratio of 1.2 with an annual volatility of 15%. If you increase leverage by 2x, what happens to the Sharpe ratio, and what are the hidden risks?
6. Describe the mechanics of a variance swap. How would you price it, and what are its advantages over standard volatility derivatives?
7. An investor holds a portfolio with a correlation matrix that exhibits time-varying correlations. How would you model this using Dynamic Conditional Correlation (DCC) models?
8. What is the difference between systematic and idiosyncratic risk? How would you decompose portfolio risk using factor models?
9. A hedge fund's portfolio exhibits negative convexity. Explain this concept and its implications for portfolio rebalancing during market stress.
10. How would you calculate the marginal contribution to risk (MCR) for an individual position in a multi-asset portfolio?
11. Explain the concept of liquidity-adjusted VaR. How does illiquid asset concentration affect tail risk measurement?
12. A portfolio manager notices that correlation across assets spikes during market downturns. What framework would you use to model this behavior?
13. How would you construct a stress test for a portfolio with exposure to multiple asset classes, currencies, and derivatives?
14. What is the relationship between skewness, kurtosis, and tail risk? How would you adjust your risk models to account for non-normal return distributions?
15. A fund has a Sortino ratio of 1.8 compared to a Sharpe ratio of 1.2. What does this tell you about the fund's return distribution and risk profile?
16. Derive the Black-Scholes pricing formula from first principles using risk-neutral valuation. What are the key assumptions, and how would you modify them for American options?
17. A trader enters a straddle position (long call and put at the same strike). What market conditions would profit this position, and how would you hedge gamma risk?
18. Explain the concept of implied volatility smile/skew. What causes this phenomenon, and how would you trade it?
19. How would you price a barrier option using Monte Carlo simulation? What variance reduction techniques would you apply?
20. A fund holds a large position in convertible bonds. How would you decompose the valuation into equity, bond, and option components?
21. What is the relationship between vega and realized volatility? How would you construct a volatility arbitrage strategy?
22. Explain the mechanics of a swaption. How does the Black model differ from Black-Scholes for interest rate derivatives?
23. A portfolio manager wants to reduce duration risk without selling bonds. What derivative strategies would you recommend, and what are the trade-offs?
24. How would you price a credit default swap (CDS)? What factors drive CDS spreads, and how would you identify mispricings?
25. Describe the concept of gamma decay. How would you dynamically hedge a short gamma position?
26. What is a quanto derivative? How would you price a quanto call option on a foreign equity index?
27. Explain the mechanics of a TRS (Total Return Swap). What are its use cases in hedge fund and PE strategies?
28. How would you price an American option using binomial trees versus finite difference methods? What are the computational trade-offs?
29. A trader has a short volatility position (short straddle). How would you calculate the breakeven points and manage the position during volatile markets?
30. What is the relationship between realized volatility and implied volatility? How would you construct a volatility forecasting model?
31. How would you design a mean-reversion trading strategy? What statistical tests would you use to validate mean reversion, and how would you avoid look-ahead bias?
32. Explain the methodology of principal component analysis (PCA) applied to a covariance matrix. How would you use PCA to reduce dimensionality in factor models?
33. A hedge fund uses machine learning to predict asset returns. What are the key challenges (overfitting, data leakage, regime change), and how would you address them?
34. How would you construct a factor model using linear regression? What diagnostic tests would you perform to ensure model validity?
35. Describe the concept of bootstrapping in financial analysis. How would you use bootstrap methods to estimate confidence intervals for portfolio returns?
36. What is the difference between time-series cross-validation and cross-validation in machine learning? Why is time-series cross-validation critical for backtesting?
37. How would you detect structural breaks in financial time series? What methods would you use?
38. A quant model shows high in-sample performance but low out-of-sample performance. What are the potential causes, and how would you diagnose this?
39. Explain the Kalman filter and its applications in finance (e.g., estimating hidden state variables, tracking alpha signals).
40. How would you model regime-switching behavior in asset returns? What are the use cases in portfolio construction?
41. What is the difference between supervised and unsupervised learning? Provide examples of each applied to finance.
42. How would you implement a clustering algorithm to identify similar stocks or market regimes?
43. Explain the concept of feature importance in machine learning models. How would you identify the most influential variables in a predictive model?
44. What is adversarial robustness in machine learning, and why is it critical for financial models exposed to market stress?
45. How would you validate a machine learning model's performance using ROC curves, precision-recall, and other metrics?
46. A portfolio manager wants to match a 10-year liability using bond holdings. How would you construct a bullet versus ladder strategy?
47. Explain the concept of key rate duration. How would you use it to manage interest rate risk in a bond portfolio?
48. What is negative convexity in mortgages? How does prepayment risk affect the valuation of mortgage-backed securities (MBS)?
49. How would you model the term structure of interest rates using the Nelson-Siegel model? What are its applications?
50. A corporate bond is trading at a 200 bps spread over Treasuries. How would you estimate the probability of default using the spread information?
51. Explain the mechanics of a credit spread trade. How would you identify mispricings between corporate bonds and CDS?
52. What is basis risk in fixed income? Provide examples and strategies to minimize it.
53. How would you price a floating-rate note with caps and floors? What is the relationship between cap/floor pricing and swaption pricing?
54. A bank manager wants to immunize a bond portfolio against interest rate changes. Explain the duration matching strategy and its limitations.
55. What is the difference between nominal yield and real yield? How would you construct a breakeven inflation analysis?
56. Explain the concept of option-adjusted spread (OAS). How does it differ from nominal spread?
57. How would you construct a credit model to predict corporate defaults? What variables would you include?
58. What is a CDS basis? How would you trade the basis between CDS and cash bonds?
59. Explain the mechanics of a collateralized debt obligation (CDO). What are the risks, and how would you analyze tranches?
60. How would you analyze a distressed credit situation? What metrics would you focus on?
61. You discover that your backtesting results show a Sharpe ratio of 2.0, but live trading shows 0.8. What are the likely causes of this discrepancy?
62. How would you design a proper backtesting framework to avoid look-ahead bias, survivorship bias, and data snooping?
63. Explain the concept of walk-forward optimization. How would you validate a trading strategy using this method?
64. What is the difference between parametric and non-parametric bootstrapping in backtesting? When would you use each?
65. How would you stress test a trading strategy against historical market crises (e.g., 2008, COVID-19)?
66. What is Monte Carlo simulation, and how would you use it to estimate the probability distribution of portfolio returns?
67. A strategy shows high Sharpe ratio in-sample but fails out-of-sample. How would you diagnose the problem using performance attribution?
68. Explain the concept of slippage in backtesting. How would you model realistic market impact costs?
69. What is transaction cost analysis (TCA), and how would you incorporate it into your backtesting framework?
70. How would you detect and eliminate data snooping bias in your research process?
71. What is the Sharpe ratio's relationship to the information ratio? How would you compare active managers using these metrics?
72. Explain the concept of maximum drawdown. How would you construct a strategy that minimizes drawdowns while maximizing returns?
73. How would you perform a sensitivity analysis on a trading strategy to identify parameter robustness?
74. What is the Calmar ratio, and how does it compare to the Sharpe ratio for evaluating hedge fund performance?
75. How would you analyze the return distribution of a strategy to identify skewness, kurtosis, and tail risk?
76. A long/short equity hedge fund holds 100 long positions (average position size 1.5%) and 50 short positions (average position size 2%). What is the net exposure and gross exposure? How would you interpret these metrics?
77. A fund manager identifies a stock that is fundamentally undervalued but has been declining 15% annually. How would you determine if this is a shorting opportunity or a value trap?
78. Explain the mechanics of shorting a stock. What are the costs (borrow costs, dividends, short squeezes), and how would you manage them?
79. A long/short fund has a beta of 0.3 with an information ratio of 1.5. What does this tell you about the fund's alpha generation and risk profile?
80. How would you construct a market-neutral long/short portfolio? What constraints would you impose?
81. A short position in a small-cap stock suddenly spikes 50% due to a takeover announcement. How would you manage this position?
82. Explain the difference between statistical arbitrage and fundamental long/short investing. What are the skill sets required for each?
83. How would you identify pairs trading opportunities? What statistical tests would you use to validate a pair?
84. A fund wants to hedge sector exposure. Should it use index futures, short sector ETFs, or individual stock shorts? What are the trade-offs?
85. How would you analyze the quality of a company's earnings? What metrics and red flags would you monitor?
86. A fund has high conviction in a short position but wants to reduce capital at risk. How would you structure a collar or other hedge?
87. Explain the concept of short-covering rallies. How would you exploit this phenomenon?
88. How would you identify potential takeover targets? What due diligence would you conduct?
89. A fund manager notices insider buying in a stock. Is this a bullish signal, and how would you validate the conviction?
90. How would you manage concentration risk in a long/short portfolio with few positions?
91. A merger arbitrage fund identifies a pending acquisition where the acquirer's stock is trading at $50, the target's stock is at $42, and the deal price is $45. What is the arbitrage spread, and what risks are present?
92. Explain the types of deal risk in merger arbitrage (regulatory, financing, shareholder vote). How would you model the probability of deal completion?
93. A hostile takeover is announced with multiple bidders. How does this affect the arb spread, and what opportunities arise?
94. How would you analyze the regulatory environment for a cross-border merger? What approval risks would you assess?
95. A merger is announced but the deal has 18 months to close. How would you compare the arb spread to the risk-free rate and assess whether it's attractive?
96. Explain the concept of deal spread compression. When would you expect it to occur, and how would you position your portfolio?
97. A debt-financed acquisition faces potential financing risk. How would you assess the probability of deal break due to financing failure?
98. How would you model shareholder vote risk in a merger? What factors influence shareholder approval probability?
99. A fund is considering a long position in the acquirer (synergy play) in addition to the arb spread. How would you structure this dual position?
100. Explain the concept of reverse merger arbitrage. When would this trade be attractive?
101. How would you analyze antitrust concerns in a merger? What precedents would you review?
102. A merger agreement includes material adverse change (MAC) clauses. How would you interpret these, and what triggers them?
103. How would you hedge currency risk in a cross-border M&A arbitrage?
104. A merger is announced at a 30% premium. Is the high premium a sign of strong synergies or deal risk?
105. How would you structure a portfolio of merger arb trades to optimize risk/reward?
106. A distressed company is trading at 50% of book value. How would you conduct fundamental due diligence to assess if it's a turnaround or a value trap?
107. A company files for bankruptcy. What is your framework for analyzing the equity's potential recovery value?
108. Explain the concept of emergence equity. How would you calculate expected returns from a Chapter 11 emergence scenario?
109. A distressed bond is trading at 40 cents on the dollar. How would you estimate the recovery value and probability of default?
110. How would you model the dilution impact on existing shareholders from a debt-to-equity conversion in bankruptcy?
111. A company negotiates a debt restructuring agreement. How would you analyze the impact on equity value?
112. Explain the concept of a pre-packaged bankruptcy (prepack). How does it differ from a traditional bankruptcy, and what are the implications for equity holders?
113. How would you analyze management's credibility and capability during a restructuring process?
114. A distressed company has multiple asset classes (debt, equity, preferred). How would you structure positions across the capital structure?
115. How would you monitor covenant violations and liquidity in a distressed situation?
116. Explain the concept of control contests in bankruptcy. How would you bet on the outcome?
117. A creditor committee is formed to negotiate a restructuring plan. How would you forecast the outcome?
118. How would you analyze environmental or legal liabilities that could impair recovery value?
119. A turnaround situation requires significant operational improvements. How would you assess management's ability to execute?
120. How would you position a portfolio to profit from industry consolidation in a distressed sector?
121. A systematic hedge fund uses machine learning to predict intraday price movements. What are the key challenges (overfitting, regime change, latency), and how would you address them?
122. A trend-following system generates signals based on moving average crossovers. How would you optimize the moving average periods, and what walk-forward validation would you conduct?
123. Explain the concept of risk parity. How would you construct a risk parity portfolio, and what are its historical performance characteristics?
124. A volatility arbitrage strategy shorts out-of-the-money (OTM) calls and puts. How would you manage gamma risk dynamically?
125. How would you design a statistical arbitrage system to identify mispricings across related securities?
126. A fund trades mean-reverting strategies across multiple asset classes. How would you identify which markets exhibit mean reversion and avoid false signals?
127. Explain the concept of clustering in returns. How would you exploit clustering patterns?
128. A systematic fund's algorithm identifies a pattern that has generated alpha for the last 5 years. What validation tests would you conduct before deploying capital?
129. How would you construct a machine learning model to predict regime changes (bull/bear/sideways markets)?
130. A algorithmic trading system trades 1000+ times per day with sub-second latencies. What are the infrastructure, execution, and regulatory risks?
131. How would you design a stop-loss framework for a systematic trading strategy without inducing whipsaw losses?
132. A momentum strategy performs well in up markets but struggles in sideways markets. How would you modify the strategy to adapt?
133. Explain the concept of factor rotation. How would you systematically rotate between value, momentum, and quality factors?
134. How would you identify and eliminate data snooping bias when developing systematic trading strategies?
135. A fund uses sentiment analysis from social media to generate trading signals. How would you validate the signal's predictive power?
136. A macro hedge fund has a conviction that central bank policy will tighten. How would you structure a position to profit from this view?
137. Explain the relationship between interest rates and currency moves. How would you model this relationship?
138. A fund expects stagflation. How would you position a portfolio to profit from this scenario?
139. Oil prices have declined 50% over 12 months. How would you assess whether prices are cheap or in a structural downtrend?
140. A crude oil storage facility is at capacity. How does this affect the contango/backwardation structure of futures?
141. Explain the concept of basis trading in commodities. How would you identify mispricings?
142. A macro fund wants to hedge inflation risk. What instruments (TIPS, commodities, etc.) would you use?
143. How would you analyze geopolitical events (wars, sanctions, elections) and their potential impact on markets?
144. A currency is trading at a significant premium to purchasing power parity (PPP). Is it overvalued, and how would you trade this?
145. Explain the carry trade concept. How would you identify profitable carry opportunities and manage carry-trade unwinding risk?
146. A country's central bank intervenes in the currency market. How would you assess the effectiveness and sustainability of the intervention?
147. How would you model the impact of energy prices on equity market returns?
148. A commodity index has been declining, but the spread between spot and futures has widened. What does this tell you?
149. How would you hedge agricultural exposure for a commodity trading fund?
150. Explain the relationship between the US dollar and emerging market asset prices. How would you exploit this relationship?
151. A Series A startup is valued at $20M pre-money with $5M investment. What is the post-money valuation, and what ownership stake does the VC receive?
152. A Series C startup has annual revenue of $50M and is growing at 80% YoY. Using the Power Law of VC, what would be an appropriate exit valuation in 5 years?
153. How would you estimate the TAM (Total Addressable Market) for an enterprise SaaS startup? What bottoms-up and top-down approaches would you use?
154. A startup claims it will reach profitability within 18 months. How would you validate this claim through unit economics analysis?
155. Explain the concept of "burn rate" in VC. If a startup has $5M in cash, $1M monthly burn, and is growing revenue at 10% MoM, how long is the runway?
156. How would you analyze a startup's competitive moat? What defensibility metrics would you assess?
157. A startup's customer acquisition cost (CAC) is $500, and the customer lifetime value (LTV) is $2000. Is this unit economics attractive?
158. How would you evaluate a founding team's background, skills, and ability to execute? What are the red flags?
159. A startup's product roadmap is aggressive, but the engineering team is small. How would you assess execution risk?
160. Explain the concept of "product-market fit." How would you determine if a startup has achieved it?
161. A startup is in a capital-efficient business but is raising at a high valuation. Is this justified, or is there downside risk?
162. How would you analyze the quality of a startup's existing investors and board composition?
163. A startup has significant technical debt. How would you assess the cost to remediate and its impact on future velocity?
164. How would you model the impact of competition on a startup's growth projections?
165. A startup's revenue is growing, but customer churn is accelerating. What does this signal, and how would you dig deeper?
166. A VC fund has a 2x gross multiple and a 1.8x net multiple (after fees and carry). What does this tell you about the fund's performance and fee structure?
167. A $500M VC fund charges 2% management fees and 20% carry. Over a 10-year fund life, what are the cumulative fees and carry?
168. Explain the concept of "J-curve" in VC fund performance. Why do early-vintage funds often underperform before outperforming later?
169. A VC firm has invested in 20 startups. 10 have failed (valued at $0), 8 return the invested capital (1x multiple), and 2 generate 20x returns. What is the MOIC?
170. How would you calculate the IRR of a VC fund given investments over multiple years and exits at different times?
171. A VC fund has written off 40% of its portfolio (deemed total losses). How does this affect fund returns, and what does it signal?
172. Explain the concept of "power law" in VC returns. Why do a few winners generate outsized returns?
173. A VC fund's net IRR is 8%, below the target of 20%. What are the likely causes, and how would you improve performance?
174. How would you analyze the quality of a VC fund's historical exits? What metrics would you review?
175. A VC fund has a high average multiple but uneven distribution (1 winner, many failures). Is this a successful fund?
176. Explain the concept of "dry powder" in VC. How does unutilized capital affect fund returns?
177. How would you model the impact of follow-on investment reserves on fund returns?
178. A GP is raising a new fund and claims a 3x return target with $200M deployment. Is this realistic?
179. How would you evaluate a VC fund's sector specialization? Are generalists or specialists better?
180. Explain the concept of anti-dilution in VC. How would you model the impact on cap tables?
181. A SaaS startup has MRR (Monthly Recurring Revenue) of $100K with 5% MoM growth. What is the projected ARR (Annual Recurring Revenue) in 12 months?
182. Explain the relationship between CAC Payback Period and LTV. If CAC payback is 18 months and LTV is 36 months, is this unit economics acceptable?
183. A SaaS startup has an MRR churn rate of 5% and new customers adding $50K MRR. What is the net revenue growth rate?
184. How would you calculate the Magic Number (growth efficiency) for a SaaS company? What threshold indicates efficient growth?
185. A startup's Rule of 40 score (growth rate + profit margin) is 35. What does this tell you about the business model?
186. Explain the concept of negative churn. When does a SaaS company achieve it, and how does it affect valuations?
187. A SaaS startup spends 40% of revenue on S&M. Is this too high, or is it efficient given the growth?
188. How would you analyze a SaaS startup's payback period for new sales? What is a healthy benchmark?
189. A startup has high CAC but also high LTV. Should a VC invest, or is the payback period the limiting factor?
190. Explain the concept of "land and expand." How would you model the expansion revenue contribution?
191. A SaaS startup is targeting enterprise customers with 6-month sales cycles. How would you model the cash flow impact?
192. How would you analyze the quality of recurring revenue vs. one-time revenue?
193. A startup's NPS (Net Promoter Score) is 60. What does this signal about product quality and future growth?
194. Explain the relationship between product development cycles and sales cycles in enterprise SaaS.
195. How would you model the impact of price increases on churn and LTV?
196. A VC investor made a $2M Series A investment in a startup. The company is underperforming, and the Series B requires a 20% down round. Should the VC invest?
197. Explain the concept of "signaling risk." How does a down round affect a startup's momentum and future fundraising?
198. A startup's founders are in conflict about the strategic direction. As a board member, how would you mediate?
199. A startup needs a bridge loan to extend runway before the Series B closes. How would you structure this?
200. A founder proposes a pivoting the business model. How would you evaluate this decision as a board member?
201. Explain the concept of "governance rights" in VC term sheets. What protections do VCs typically require?
202. A startup is acquiring a competitor. How would you analyze the strategic fit and integration risks?
203. A founder wants to hire a family member for a senior role. How would you handle this as a board member?
204. How would you evaluate a founder's CEO transition? When should a founder step aside?
205. A startup has multiple term sheets from different VCs at different valuations. How would you advise the founder on the decision?
206. Explain the concept of "liquidation preferences." How do they affect returns to common stockholders?
207. A startup is in a hostile acquisition scenario. As a board member, how would you navigate this?
208. How would you manage a situation where a major customer is also an investor?
209. A startup is struggling to hit milestones, and the VC wants to replace the CEO. How would you approach this?
210. Explain the concept of "drag-along" and "tag-along" rights. Why are these important?
211. A PE firm acquires a company for $100M with 60% debt ($60M) and 40% equity ($40M). If EBITDA is $15M and interest rates are 5%, what is the leverage ratio and interest coverage?
212. Explain the mechanics of a leveraged buyout (LBO). How does financial leverage amplify returns?
213. A company has $100M in EBITDA with 4x leverage. The PE firm plans to reduce leverage to 2x within 5 years. What EBITDA growth would be required (assuming debt is paid down with FCF)?
214. How would you model a management rollover or ratchet? What are the tax implications?
215. A target company has operating leases that aren't on the balance sheet. How would you adjust the debt calculation and impact on leverage?
216. Explain the concept of "dividend recaps." How do they affect leverage and returns?
217. A PE acquisition includes earnout payments based on future performance. How would you model this in the investment return calculation?
218. How would you analyze the debt structure of a leveraged company (senior debt, subordinated debt, preferred equity)? What are the covenants?
219. A company has significant off-balance-sheet liabilities (pension obligations, environmental liabilities). How would you adjust the purchase price allocation?
220. Explain the concept of "sponsor NPV." How does this affect deal pricing?
221. A target company has seasonal working capital swings. How would you model this in the LBO model?
222. How would you analyze refinancing risk in an LBO? What happens if rates spike?
223. A PE acquisition includes a seller note (seller financing). How would this affect the return profile?
224. How would you model the tax impact of an LBO on the exit return?
225. A company has significant CapEx requirements to maintain operations. How would this affect FCF and deleveraging?
226. A PE-backed company's EBITDA margin is 15%, while competitors are at 20%. How would you identify margin expansion opportunities?
227. Explain the concept of "operational value creation." What are the main levers (pricing, cost reduction, growth)?
228. A company has sales, general, and administrative (SG&A) expenses at 25% of revenue. How would you benchmark and identify reduction opportunities?
229. How would you implement pricing increases without losing customers? What pricing strategies would you consider?
230. A company's customer acquisition cost is rising while churn is increasing. How would you address these issues?
231. Explain the concept of "synergies" in PE deals. How would you identify and underwrite revenue and cost synergies?
232. A company has significant manual processes. How would you evaluate the cost of automation and the payback period?
233. How would you implement supply chain optimization in a PE-backed company?
234. A company has excess inventory. How would you optimize working capital without disrupting operations?
235. Explain the concept of "same-store sales" growth. How would this differ from overall revenue growth?
236. A company's net working capital is 20% of revenue. Is this excessive, and how would you reduce it?
237. How would you evaluate a company's vendor contracts? What renegotiation opportunities exist?
238. A PE firm is considering add-on acquisitions to a platform company. How would you evaluate the financial impact?
239. How would you implement a transformation program in a PE-backed company? What KPIs would you track?
240. Explain the concept of "best practices" sharing across a PE portfolio. How would you systematize this?
241. A PE firm acquired a company 3 years ago at 6x EBITDA for $300M with 60% leverage. EBITDA has grown to $75M. If the exit multiple is 8x, what is the IRR?
242. Explain the relationship between exit timing and returns. How would you decide when to sell?
243. A company can be exited via strategic sale, secondary sale (to another PE firm), or IPO. What are the pros and cons of each?
244. An IPO is planned for a PE-backed company, but market conditions deteriorate. How would you adjust the exit timeline?
245. A strategic buyer emerges for a PE-backed company at 9x EBITDA. How would you evaluate this against holding for a year?
246. Explain the concept of "exit readiness." What preparation would you do pre-exit?
247. A company's leverage is still 4x at the targeted exit date. What options exist to complete the exit?
248. How would you model the impact of earnout terms on exit returns?
249. A management team wants to stay involved in the company post-exit through a management continuation plan. How would you structure this?
250. Explain the concept of "carry" in PE. How does the distribution of carry affect fund returns and GP incentives?
251. A secondary PE investor is purchasing a fund's position in a PE-backed company. How would you value this transaction?
252. How would you compare the returns of a strategic exit (to an operating company) vs. a financial exit (to another PE firm)?
253. A company has achieved significant growth, but the multiple has compressed due to market conditions. How would you still achieve target returns?
254. Explain the concept of "dividend coverage." What factors affect the ability to pay dividends?
255. How would you analyze the tax efficiency of different exit structures?
256. A PE fund has invested in 15 companies with varying returns. How would you manage the portfolio to optimize overall fund returns?
257. Explain the concept of "dry powder." How much reserve should a PE fund maintain for follow-on investments?
258. A PE fund's largest investment is underperforming. Should you invest more capital (support) or write down the position?
259. How would you allocate capital across multiple investments to optimize the portfolio's return profile?
260. A PE fund has a target IRR of 25% and a target MOIC of 3x. Are these consistent, and over what time period?
261. Explain the concept of "fund aging." How does the progression from early investments to mature investments affect cash flows?
262. A PE fund is considering a major add-on acquisition for its largest platform company. How would you evaluate the impact on fund returns?
263. How would you benchmark a PE fund's performance against peer funds and public markets?
264. A PE fund is between funds (moving from Fund III to Fund IV). How would you manage the transition?
265. Explain the concept of "step-downs" in PE fees. How do they affect GP-LP alignment?
266. A PE fund has written off 30% of its portfolio (invested capital). How does this affect projected fund returns?
267. How would you manage portfolio company board meetings to drive performance?
268. A portfolio company requires a significant additional investment due to market disruption. Should the fund invest or let it fail?
269. Explain the concept of "clawback." When would a GP owe clawback to LPs?
270. How would you decide between increasing your stake in a winner (follow-on) vs. deploying capital to new investments?
271. A family office business (founder-led, non-public) is being acquired by a PE firm. How would you structure the deal to maintain founder involvement?
272. A turnaround situation requires significant operational changes and cost reduction. How would you approach this?
273. A public company is being taken private in an LBO. What regulatory approvals are required, and what adjustments would you make to the model?
274. A distressed company is being acquired out of bankruptcy. How would you model the impact on equity value and PE returns?
275. A company operates in a highly regulated industry (healthcare, financial services). How would you structure the PE investment?
276. A platform company is being built through add-on acquisitions. How would you model the revenue and cost synergies?
277. A company has significant customer concentration (top 3 customers = 60% of revenue). How would you assess this risk and manage it?
278. A PE firm is acquiring a company with significant pension obligations. How would this affect the deal valuation?
279. Explain the concept of "tuck-in" acquisitions in PE. How do they differ from larger add-ons?
280. A company is in a sunset industry (declining market demand). How would you evaluate the investment thesis?
281. A company has key person risk (founder/CEO is critical to success). How would you mitigate this?
282. A hostile acquisition of a PE-backed company emerges. How would you evaluate the takeover threat and options?
283. A company is being acquired with seller financing (earn-out + seller note). How would you model the risk and returns?
284. A PE firm is acquiring a competitor to an existing portfolio company. How would you approach the integration?
285. A company's supply chain is heavily dependent on one geographic region facing geopolitical risk. How would you assess this?
286. A PE firm is considering an LBO of a high-growth tech company currently valued at $500M. The target has $50M EBITDA, growing at 30% YoY. Design the entire investment thesis: valuation, leverage strategy, operational improvements, and exit strategy.
287. A hedge fund runs a long/short equity strategy across 50 positions. A major sector correction occurs, and the fund's hedges are underwater. How would you rebalance the portfolio to manage risk?
288. A VC fund is evaluating two Series B opportunities: Startup A (early-stage, high risk, 10x+ potential) vs. Startup B (mature, lower risk, 3x potential). How would you decide?
289. A distressed debt fund is analyzing a company in Chapter 11 bankruptcy with claims in senior debt, subordinated debt, and equity. How would you model recovery scenarios?
290. A systematic hedge fund discovers a profitable trading signal but it's only available to 5% of the market during illiquid hours. What are the practical considerations for implementation?
291. A PE-backed SaaS company is experiencing CAC inflation. Design an operational improvement plan to restore unit economics.
292. A macro hedge fund is positioning for a potential recession. Design a portfolio strategy that profits during downturns while minimizing upside opportunity cost.
293. A PE secondary fund is acquiring a fund position in a mature tech company. How would you value the position and forecast returns?
294. A hedge fund is considering a merger arbitrage position in a deal with 40% spread but significant regulatory risk. How would you model the probability-adjusted returns?
295. A VC-backed startup is raising a Series C but is experiencing declining growth rates. How would you assess valuation and fund allocation?
296. A PE firm is creating a platform company through an LBO, planning 3 major add-on acquisitions. Model the value creation from both financial leverage and operational synergies.
297. A hedge fund runs a volatility arbitrage strategy. The market experiences a major shock, and implied volatility spikes. How would you manage mark-to-market losses and tail risk?
298. A distressed investor is analyzing a turnaround situation. Model the required EBITDA growth, margin improvement, and leverage reduction needed to achieve a 20% IRR.
299. A VC firm is developing a thesis on climate tech startups. Design the due diligence framework, key metrics, and exit scenarios.
300. A PE fund is evaluating a dividend recapitalization opportunity. Model the impact on leverage, cash flow, and exit returns. What are the risks?
